ArticleVaccine: X2023

Nationwide safety surveillance of COVID-19 mRNA vaccines following primary series and first booster vaccination in Singapore.

Sreemanee Raaj Dorajoo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.